In the case of Uterine Fibroid Embolization, the number of patients receiving treatments also demonstrates the number of procedures being performed using Microspheres compared to PVA particles. The changes in Essure® procedures provides a context for the adverse health effects currently being publicized and the impact it is having on potential patients. Finally, for both Female Urinary Incontinence Sling procedures and Pelvic Organ Prolapse procedures, there is a 1:1 ratio between unit sales and the number of procedures performed. However, the procedure numbers illustrate doctor and patient preferences as there is a shift in the types of slings and meshes used for procedures.
'
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
PROCEDURE NUMBERS 11
MARKETS INCLUDED 12
KEY REPORT UPDATES 14
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
1.1 RESEARCH SCOPE 18
1.2 IDATA’S 9-STEP METHODOLOGY 18
1.2.1 Step 1: Project Initiation & Team Selection 18
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 20
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 21
1.2.4 Step 4: Performing Primary Research 22
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 24
1.2.6 Step 6: Market Forecast and Analysis 25
1.2.7 Step 7: Identify Strategic Opportunities 27
1.2.8 Step 8: Final Review and Market Release 28
1.2.9 Step 9: Customer Feedback and Market Monitoring 29
COUNTRY PROFILES 30
2.1 INTRODUCTION 30
2.1.1.1 Population 30
2.1.1.2 Median Age 32
2.1.1.3 GDP Per Capita 32
2.1.1.4 Price Index 33
2.2 GERMANY 34
2.3 FRANCE 35
2.4 UNITED KINGDOM 36
2.5 ITALY 37
2.6 SPAIN 38
2.7 BENELUX 39
2.8 SCANDINAVIA 40
2.9 AUSTRIA 41
2.10 SWITZERLAND 43
2.11 PORTUGAL 44
EUROPEAN GYNECOLOGICAL DEVICE MARKET PROCEDURE NUMBERS 45
3.1 PROCEDURE ANALYSIS AND FORECAST 45
3.1.1 Introduction 45
3.1.2 Assisted Reproduction Procedures 46
3.1.3 Uterine Fibroid Embolization Procedures 48
3.1.4 Transcervical Female Sterilization Procedures 50
3.1.5 Female Urinary Incontinence Sling Procedures 52
3.1.5.1 Synthetic Sling Procedures 54
3.1.5.2 Non-Synthetic Sling Procedures 55
3.1.6 Pelvic Organ Prolapse Procedures 56
3.1.6.1 Trans-Vaginal Mesh Procedures 58
3.1.6.2 Sacrocolpopexy Procedures 59
ABBREVIATIONS 60
Chart 1 1: Gynecological Device Market by Segment, Europe, 2012 – 2022 3
Chart 1 2: Gynecological Device Market Overview, Europe, 2015 & 2022 3
Chart 2 1: Country Profile, Germany, 2015 34
Chart 2 2: Country Profile, France, 2015 35
Chart 2 3: Country Profile, United Kingdom, 2015 36
Chart 2 4: Country Profile, Italy, 2015 37
Chart 2 5: Country Profile, Spain, 2015 38
Chart 2 6: Country Profile, Benelux, 2015 39
Chart 2 7: Country Profile, Scandinavia, 2015 40
Chart 2 8: Country Profile, Austria, 2015 42
Chart 2 9: Country Profile, Switzerland, 2015 43
Chart 2 10: Country Profile, Portugal, 2015 44
Figure 1 1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3) 4
Figure 1 2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3) 5
Figure 1 3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2015 6
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in Gynecological Device Market, Europe, 2012 – 2016 10
Figure 1 9: Gynecological Procedures Covered, Europe, 2015 11
Figure 1 10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2) 12
Figure 1 11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2) 13
Figure 1 12: Key Report Updates (1 of 3) 14
Figure 1 13: Key Report Updates (2 of 3) 15
Figure 1 14: Key Report Updates (3 of 3) 16
Figure 1 15: Version History 17
Figure 2 1: Population by Country, Europe, 2015 30
Figure 2 2: Population, Benelux, 2015 31
Figure 2 3: Scandinavia, Europe, 2015 31
Figure 2 4: GDP per Capita, Europe, 2015 32
Figure 3 1: Assisted Reproduction Procedures by Country, Europe, 2011 – 2022 47
Figure 3 2: Uterine Fibroid Embolization Procedures by Country, Europe, 2012 – 2022 49
Figure 3 3: Transcervical Female Sterilization Procedures by Country, Europe, 2012 – 2022 51
Figure 3 4: Female Urinary Incontinence Sling Procedures by Country, Europe, 2012 – 2022 53
Figure 3 5: Synthetic Sling Procedures by Country, Europe, 2012 – 2022 54
Figure 3 6: Non-Synthetic Sling Procedures by Country, Europe, 2012 – 2022 55
Figure 3 7: Pelvic Organ Prolapse Procedures by Country, Europe, 2012 – 2022 57
Figure 3 8: Trans-Vaginal Mesh Procedures by Country, Europe, 2012 – 2022 58
Figure 3 9: Sacrocolpopexy Procedures by Country, Europe, 2012 – 2022 59
Bayer
Karl Storz
Cooper Surgical
Olympus
Richard Wolf
Cook Medical
Johnson & Johnson
Astora Women's Health
Vitrolife
Boston Scientific
Johnson & Johnson
Hologic
